Her main research concerns Psychosis, Psychiatry, Schizophrenia, First episode and Internal medicine. Her studies in Psychosis integrate themes in fields like Cognition, Neuroscience, Case-control study and Antipsychotic. Her study looks at the intersection of Psychiatry and topics like Incidence with Etiology and Cross-sectional study.
The various areas that Paola Dazzan examines in her Schizophrenia study include Bipolar disorder, Magnetic resonance imaging, Clinical psychology, Pediatrics and Cohort. Paola Dazzan interconnects Mental health, White British, Voxel-based morphometry and Grey matter in the investigation of issues within First episode. Her work is dedicated to discovering how Internal medicine, Endocrinology are connected with Interleukin and Inflammation and other disciplines.
The scientist’s investigation covers issues in Psychosis, Psychiatry, Schizophrenia, First episode and Clinical psychology. Her research investigates the connection between Psychosis and topics such as Internal medicine that intersect with issues in Endocrinology. Her study in the field of First episode psychosis, Mental health, Cognition and Cannabis also crosses realms of In patient.
Her Schizophrenia research includes themes of Neuroscience, Depression and Cohort. Her research on First episode often connects related topics like Pediatrics. Her study in the fields of Psychopathology under the domain of Clinical psychology overlaps with other disciplines such as Sexual abuse.
Her primary areas of investigation include Psychosis, Schizophrenia, Internal medicine, First episode psychosis and Clinical psychology. Her biological study spans a wide range of topics, including First episode, Longitudinal study, Neuroimaging and Antipsychotic. Her work on Schizophreniform disorder as part of general Schizophrenia study is frequently connected to Sexual abuse, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Her Internal medicine research includes elements of Clozapine, Oncology, Endocrinology and Positive and Negative Syndrome Scale. Her First episode psychosis research entails a greater understanding of Psychiatry. Her work on Psychiatric diagnosis as part of general Psychiatry research is often related to Outcome, thus linking different fields of science.
Her primary scientific interests are in Psychosis, Schizophrenia, Internal medicine, Clinical psychology and First episode psychosis. The Psychosis study combines topics in areas such as First episode, Neuroimaging, Young adult and Antipsychotic. Her Schizophrenia study combines topics in areas such as White matter, Grey matter and Cognition.
Her studies deal with areas such as Biological psychiatry, Gene expression, Oncology and Positive and Negative Syndrome Scale as well as Internal medicine. Her Clinical psychology research is multidisciplinary, incorporating perspectives in Dopamine and Depression. Her Confidence interval research focuses on subjects like Psychiatry, which are linked to Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center ÆSOP study
James B Kirkbride;Paul Fearon;Craig Morgan;Paola Dazzan.
Archives of General Psychiatry (2006)
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study
Paul Fearon;James B. Kirkbride;Craig Morgan;Paola Dazzan.
Psychological Medicine (2006)
High-potency cannabis and the risk of psychosis
Marta Di Forti;Craig Morgan;Paola Dazzan;Carmine Pariante.
British Journal of Psychiatry (2009)
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Marta Di Forti;Arianna Marconi;Elena Carra;Sara Fraietta.
The Lancet Psychiatry (2015)
Reliability and Comparability of Psychosis Patients’ Retrospective Reports of Childhood Abuse
Helen L. Fisher;Thomas K. Craig;Paul Fearon;Kevin D. Morgan.
Schizophrenia Bulletin (2011)
Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users.
Marta Di Forti;Hannah M Sallis;Fabio Allegri;Antonella Trotta.
Schizophrenia Bulletin (2014)
Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period
Ian Richard Jones;Prabha S. Chandra;Paola Dazzan;Louise M. Howard.
The Lancet (2014)
Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.
S. Navari;Paola Dazzan.
Psychological Medicine (2009)
Altering the course of schizophrenia: progress and perspectives
Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead.
Nature Reviews Drug Discovery (2016)
Regional gray matter volume abnormalities in the at risk mental state
Stefan J. Borgwardt;Anita Riecher-Rössler;Paola Dazzan;Xavier Chitnis.
Biological Psychiatry (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: